About Us  |   Contact Us  |   Register  | Login  |   

Follow HedgeWorld on Twitter HedgeWorld on LinkedIn






HEDGEWORLD NEWS
Search the News
Advanced News Search
HedgeWorld News by Region
United States / Americas
Europe
Asia / Australia
International
HedgeWorld News Sections
Managed Futures & Derivatives
Daily News
Regulatory/Legal
Strategies/Analysis
Technology
Opinion
People
Indexes
Other News Features
Most Popular
LexisNexis Headlines
Reuters Headlines
The HedgeWorld Blog
Alternative Advantage Daily Newsletter
RSS Service
Sign Up For Email News Alerts
Reprints



ANALYSIS-China's equities seen overtaking India's in 2014
12/17/2013 Email this story  |  Printable Version

By Clement Tan

HONG KONG, Dec 18 (Reuters) - Chinese shares may be poised to become an unlikely star of Asian emerging markets in 2014, outshining India, thanks to cheap valuations and optimism about reforms.

Investors have been underweight China for years.

China-focused equity funds saw some net inflows in November, when the ruling Communist Party announced plans for far-reaching economic and social reforms, and analysts said once the government starts following through on those plans it would trigger a flood of money.

Foreigners have bought a net $18.8 billion worth of Indian shares this year, according to the market regulator's data.

Official statistics are not published for China, but data from fund tracker EPFR shows a net $5.5 billion outflows for the year to Dec. 11 for China-focused equity funds.

At 9.3 times forward 12-month earnings, the MSCI China is trading at a chunky discount to its 10-year median and at its widest gap to the MSCI Asia ex-Japan since the 2008 financial crisis.

And the Chinese market is trading at a 40 percent discount to MSCI India on a forward price-to-earnings basis, according to Thomson Reuters I/B/E/S data.

In contrast, benchmark indexes in India have hit record highs and valuations are on par with 10-year averages.

Besides looking expensive, Indian shares could also be vulnerable to shocks that could come from the U.S. Federal Reserve winding down its stimulus, current account problems, and a general election due by May next year.

At the very least, investors look unwilling to add more Indian risk and will look to make fresh allocations next year in other markets, with China firmly on their radar.

"Overall, we believe Chinese equities are just too cheap to be ignored by investors in 2014," said Desmond Tjiang, Greater China and Hong Kong equities portfolio manager at Pinebridge Investments in Hong Kong.

"Despite reforms and the broad economic slowdown, there are still a lot of industries such as mass consumption, e-commerce and environment-related sectors that should continue to grow exponentially in the coming years."

Beijing last month unveiled a bold reform plan, including pledging to free up markets, in a bid to put the world's second-largest economy on a more stable footing.

The plan sparked a rally in Chinese stocks that saw the offshore Chinese market in Hong Kong gain more than 10 percent in four sessions, before levelling off.

Some brokers, such as CLSA, said the rally lacked conviction due to an absence of institutional investors. But while some may still be wary of a market that has been in a funk since 2007, there are signs things could be turning around.

In a Nov. 21 report, Goldman Sachs said funds focused on global emerging markets and Asia were underweight China by 290 and 582 basis points respectively, suggesting a return to equal weighting alone would trigger a powerful rally.

"India may have more upside potential in the short term because markets may rally into the elections due in May, but China represents better value in the middle term," said Angelo Corbetta, Pioneer Investments' London-based head of Asian equities.

PLAYING CHINA SMART

But India's potential is starting to look stretched on valuations already. Information technology and pharmaceutical companies, which led stock indices to record highs last week, are expensive.

The MSCI India IT sub-index trades at 21 times earnings forecasts for the year ahead, well above the 12 times for the equivalent index for Asia-Pacific countries outside of Japan. The MSCI health care sub-index is starting to look similarly stretched.

In comparison, China Inc's earnings revision ratio -- the pace of earning forecast upgrades against downgrades -- has turned around, suggesting investors think Chinese companies' earnings prospects are improving.

"For three years, markets have been betting on a hard landing in China. It is time to unwind some of those bets," said the head of a Asian macro hedge fund in Hong Kong.

For the rally to last beyond early 2014, investors will expect clear steps to be taken to resolve Chinese banks' bad debt problems. They will also want to see how the reform drive will impact corporate margins and earnings, especially for giant state-owned firms.

"We will be looking for a dramatic improvement at the operating cash flow level at the next earnings. Most Chinese companies have negative working capital, which means they are subsidising their clients," Pioneer's Corbetta said. "It's all about allocating capital more efficiently."

If that happens, Chinese equities may well see a re-rating in the longer run.

"If China gets its reform right...we will move into an environment where we don't just buy the dip and sell the bounce, but you actually just buy the dip because the long-term trajectory is positive as opposed to flat to down," said Andrew Swan, Blackrock's head of Asian equities, told the Reuters Investment Summit in late November. (Additional reporting by Saikat Chatterjee, Vikram Subhedar in HONG KONG and Abhishek Vishnoi in MUMBAI; Editing by Simon Cameron-Moore)


Email This Story to a Friend   |   Display Printable Version of This Story

Story Copyright © 1999-2014 Reuters HedgeWorld All rights reserved.

HedgeWorld News is sponsored by:






Lipper    Privacy   User Policy  Legal Disclosure Copyright/DMCA  Site Map    FAQ    Glossary  Thomson Reuters for Hedge Funds
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of HedgeWorld content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. HedgeWorld is a registered trademark of Thomson Reuters.